Tackling Nonatrial Fibrillation Diseases Using Nonvitamin K Antagonist Oral Anticoagulant: by What and for Whom?

被引：0
|
作者：
Kim, Jong S. [1 ]
机构：
[1] Univ Ulsan, Dept Neurol, Asan Med Ctr, Coll Med, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea
来源：
JOURNAL OF STROKE | 2019年 / 21卷 / 03期
关键词：
D O I：
10.5853/jos.2019.02474
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [1] Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal
    Karen S. Brown
    Hamim Zahir
    Michael A. Grosso
    Hans J. Lanz
    Michele F. Mercuri
    Jerrold H. Levy
    Critical Care, 20
  • [2] Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal
    Brown, Karen S.
    Zahir, Hamim
    Grosso, Michael A.
    Lanz, Hans J.
    Mercuri, Michele F.
    Levy, Jerrold H.
    CRITICAL CARE, 2016, 20
  • [3] The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients: A Systematic Need for New Strategies
    Proietti, Marco
    Lane, Deirdre A.
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (03) : 369 - 371
  • [4] Kidney function monitoring and nonvitamin K oral anticoagulant dosage in atrial fibrillation
    Andreu Cayuelas, Jose Manuel
    Caro Martinez, Cesar
    Flores Blanco, Pedro Jose
    Elvira Ruiz, Gines
    Albendin Iglesias, Helena
    Cerezo Manchado, Juan Jose
    Bailen Lorenzo, Jose Luis
    Januzzi, James L.
    Garcia Alberola, Arcadio
    Manzano-Fernandez, Sergio
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 (06)
  • [5] A Narrative Review of Nonvitamin K Antagonist Oral Anticoagulant Use in Secondary Stroke Prevention
    Caso, Valeria
    Masuhr, Florian
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2019, 28 (09): : 2363 - 2375
  • [6] Appropriate dosing of nonvitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation
    Steinberg, Benjamin A.
    Washam, Jeffrey B.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (08) : 567 - 572
  • [7] Real-world use of nonvitamin K antagonist oral anticoagulant in atrial fibrillation patients with liver disease: A meta-analysis
    Dai, Qixin
    Deng, Xiaohong
    Zhou, Lin
    Zhang, Long
    Xiao, Xiulin
    Liao, Yonghui
    CLINICAL CARDIOLOGY, 2020, 43 (07) : 676 - 683
  • [8] The Role of Nonvitamin K Antagonist Oral Anticoagulants (NOACs) in Stroke Prevention in Patients with Atrial Fibrillation
    Kuznetsov, Sofya
    Barcelona, Robert
    Josephson, Richard A.
    Mohan, Sri K. Madan
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (05)
  • [9] Nonvitamin K Antagonist Oral Anticoagulants Reduced the Risk of Liver Injury in Atrial Fibrillation Patients
    Liu, Rongqiang
    Ye, Linsen
    Shao, Yi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (05): : 1090 - 1090
  • [10] Practical Considerations for the Nonvitamin K Antagonist Oral Anticoagulants
    Trikha, Rahul
    Kowey, Peter R.
    CARDIOLOGY, 2017, 136 (02) : 115 - 124
12345